# UNIVERSITY OF COLORADO DENVER: Novel Combination Therapies to Combat Hypermutable Carbapenem-Resistant P. aeruginosa

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF COLORADO DENVER |
| Location | Aurora, CO |
| Project | Novel Combination Therapies to Combat Hypermutable Carbapenem-Resistant P. aeruginosa |
| Project number | 7R01AI165997-05 |
| Mechanism | R01 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $744,147 |
| Awarded | 2026-09-02 |
| Project period | 2022-05-24 to 2027-04-30 |
| UEI | MW8JHK6ZYEX8 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11580378). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.